Gr Sarantis S A : COMMENTS REGARDING A DECISION OF THE GREEK ANTI-TRUST COMMITTEE
January 11, 2018 at 08:14 am EST
Share
Sarantis Group completed the acquisition of Indulona, a cosmetics brand with presence in Slovakia and Czech Republic.
More specifically, Sarantis Group signed an agreement for the acquisition of the 100% of the share capital of the Slovakian company SANECA TRADE S.R.O and its Czech subsidiary SANECA TRADE CZ S.R.O.
INDULONA products are distributed though the aforementioned companies in the Slovakian and Czech Republic markets respectively.
This acquisition, completed within the context of the Group's strategic growth plan, further enriches the Group's brand portfolio, reinforces its position as a leading consumer products company and supports further the Group's geographical footprint in its territory.
INDULONA is a well-known, award-winning cosmetics brand boasting a 70-year history of successful presence in both the Czech and the Slovakian market within the subcategories of hand care, body care and foot care. It is the most popular and No 1 selling product within the hand care category in both Czech Republic and Slovakia.
INDULONA's estimated FY 2017 sales, in Czech Republic and Slovakia, amount to 7 mil euros.
The acquisition cost amounts to 8.5 million euros and will be funded through own cash.
This acquisition, completely aligned with the Group's strategy, is a great fit within the Group's portfolio. Not only will the existing Czech business be further reinforced with a highly recognized brand name, but also, leveraging INDULONA's strong commercial operation within Slovakia, the Group's existing presence in the Slovakian market will increase significantly.
Furthermore, INDULONA, offers numerous expansion opportunities for the future within its existing and adjacent subcategories in its present markets, while the brand's know-how can be utilized in the rest of the Group's countries.
Gr. Sarantis SA published this content on 11 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 January 2018 13:14:04 UTC.
Original documenthttps://ir.sarantis.gr/en/news/investors-press?item=1787
Public permalinkhttp://www.publicnow.com/view/CE6E081EC686FF59A44C2B23518E2BCABC96DC33
Sarantis S.A. is one of the world's leading distributors of branded consumer products. Net sales break down by family of products as follows:
- cosmetic products (42.3%): perfumery and toiletry products (Antonio Banderas, BU, C.THRU, Denim, Elode, Myrto, Noxzema, Prosar, STR8, Tesori l'Oriente and Vidal), skin care products (Astrid, Bioten, Elmiplant and Kolastyna), sun screen products (Carroten, Coppertone and Piz Buint) and hair care products (Final Net and Orzene Beer);
- household products (39.8%): food preservation products (Domet, Fino, Fox, Grosik, Hewa, Jan, Korunka Sanitas and Topstar), home maintenance equipment (Afroso, Ava, Flame, Septifos and Tuboflo), insecticides (Globol, Pyrox and Teza), shoe creams (Camel), etc. ;
- other (12.4%): including health care products, dietary supplements, pregnancy tests, etc.
The remaining net sales (5.5%) are from the manufacturing of plastic packaging products (Label Polipak).
At the end of 2020, the group operated a network of nearly 110,000 sales outlets in Europe.
Net sales are distributed geographically as follows: Greece (34.6%), Poland (23.6%), Romania (14%), Ukraine (7.1%), Czech Republic (5.2%), Serbia (5.1%), Bulgaria (3.3%), Hungary (2.6%) and others (4.5%).